Search

Search Results

• AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS

  Grzegorz Helbig, Malgorzata Krawczyk-Kulis, Malgorzata Kopera, Krystyna Jagoda, Patrycja Rzepka, Aleksandra Majewska-Tessar, Marta Hejla, Slawomira Kyrcz-Krzemien

  e2014047

  2014-06-29

  https://doi.org/10.4084/mjhid.2014.047

  1484

  PDF: 875

  HTML: 1934

  Figure: 150

  Tables: 166

  ALL revision 1: 174

  response to reviewer: 159

• “IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”

  Sara Martinelli, Antonio Cuneo, Gian Matteo Rigolin

  e2016047

  2016-10-15

  https://doi.org/10.4084/mjhid.2016.047

  3958

  PDF: 1011

  HTML: 3556

  Untitled: 163

  Cneo. Fig.1: 97

  Untitled: 89

  Untitled: 110

  Untitled: 111

• SICKLE CELL DISEASE AND PREGNANCY

  Dipty Jain, Pooja Lodha, Roshan Colah, Prachi Atmapoojya, Prachi Atmapoojya

  e2019040

  2019-06-24

  https://doi.org/10.4084/mjhid.2019.040

  5814

  PDF: 3577

  HTML: 417

• DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.

  Matteo Della Porta, Cristina Picone

  e2017017

  2017-02-15

  https://doi.org/10.4084/mjhid.2017.017

  4662

  PDF: 1742

  HTML: 2100

• CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA

  Michele Bibas, Jorge J Castillo

  e2014064

  2014-10-22

  https://doi.org/10.4084/mjhid.2014.064

  2518

  PDF: 1569

  HTML: 2337

  Table1: 176

• PRENATAL DIAGNOSIS OF ?-THALASSEMIAS AND HEMOGLOBINOPATHIES

  Maria Cristina Rosatelli, Luisella Saba

  e2009011

  2009-11-15

  1155

  PDF: 358

  HTML: 6343

• HAPLOIDENTICAL TRANSPLANT WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASTIC SYNDROMES PATIENTS: THE ROLE OF PREVIOUS LINES OF THERAPY.

  Daniele Avenoso, Fabio Serpenti, Liron Barnea Slonim, Styliani Bouziana, Francesco Dazzi, Guy Hannah, Michelle Kenyon, Varun Mehra, Austin Kulasekararaj, Pramila Krishnamurthy, Mili Naresh Shah, Sharon Lionel, Antonio Pagliuca, Victoria Potter

  e2024002

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.002

  1187

  PDF: 1402

  HTML: 142

• ENDOTHELIAL NITRIC OXIDE SYNTHASE (ENOS) GENE POLYMORPHISM IS ASSOCIATED WITH AGE ONSET OF MENARCHE IN SICKLE CELL DISEASE FEMALES OF INDIA

  Sudhansu Sekhar Nishank

  e2013036

  2013-06-04

  https://doi.org/10.4084/mjhid.2013.036

  1442

  PDF: 904

  HTML: 2349

  Table: 179

• EBV CHRONIC INFECTIONS

  Eligio Pizzigallo, Delia Racciatti, Valeria Gorgoretti

  e2010022

  2010-08-09

  https://doi.org/10.4084/mjhid.2010.022

  3356

  PDF: 1535

  HTML: 7773

• THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA

  Yingying Li, Yang Li, Wenguo Cheng

  e2025073

  2025-10-31

  https://doi.org/10.4084/MJHID.2025.073

  390

  PDF: 203

  HTML: 71

• Impact of daratumumab on stem cell mobilization and transplant in patient with newly diagnosed multiple myeloma: a real word single-center study

  Mauro Passucci, Francesca Fazio, Jacopo Micozzi, Manhaz Shafii Bafti, Giovanni Manfredi Assanto, Alfonso Piciocchi, Maurizio Martelli, Maria Teresa Petrucci

  e2024041

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.041

  1205

  PDF: 1018

  Suppl. Files: 692

  HTML: 60

• CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab

  r. Salam Al-Kindi, Isra Al-Busaidi, Anil Pathare

  e2024046

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.046

  1260

  PDF: 1087

  HTML: 93

• Genetic modulators of diversity in biological expression of sickle cell anemia in patients from democratic republic of Congo

  MAMY NGOLE, MAMY NGOLE, GLOIRE MBAYABO, PAUL LUMBALA, VALERIE RACE, NONO MVUAMA, STEPHANIE DEMAN, ERIKA SOUCHE, PROSPER TSHILOBO LUKUSA, CHRIS VAN GEET, KOENRAAD DEVRIENDT, GERT MATTHIJS, AIME LUMAKA, ISABELLE CLEYNEN

  e2025001

  2024-12-31

  https://doi.org/10.4084/MJHID.2025.001

  1601

  HTML: 221

  PDF: 1190

• WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 1: EPIDEMIOLOGY, PATHOGENESIS, CLINICOPATHOLOGIC CHARACTERISTICS, DIFFERENTIAL DIAGNOSIS, RISK STRATIFICATION, AND CLINICAL PROBLEMS

  Michele Bibas, Shayna Sarosiek, Jorge J. Castillo

  e2024061

  2024-06-29

  https://doi.org/10.4084/MJHID.2024.061

  2600

  PDF: 3103

  HTML: 328

• The labyrinth of pyrexia of unknown origin: A case of intravascular B cell lymphoma

  Sujith V Cherian, Subhraleena Das, Bandita Das Basu, Robert E Hutchison

  e2013019

  2013-02-20

  https://doi.org/10.4084/mjhid.2013.019

  1709

  PDF: 659

  HTML: 2393

  Untitled: 133

  Figure 1 a: 141

  Figure 1 b: 152

  Fig 1 c: 130

  Figure 1 d: 176

• INFECTIOUS AETIOLOGY OF MARGINAL ZONE LYMPHOMA AND ROLE OF ANTI-INFECTIVE THERAPY

  Salvatore Perrone, Gianna Maria D'Elia, Alessandro Pulsoni

  e2016006

  2016-01-01

  https://doi.org/10.4084/mjhid.2016.006

  4378

  PDF: 1295

  HTML: 2141

• GROUP-BASED TRAJECTORY MODELING OF PLATELET IN PATIENTS WITH APLASTIC ANEMIA: A STUDY BASED ON THE MIMIC DATABASE

  Lang Peng, Lixin Zou, Xiaoliu Liu

  e2025012

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.012

  936

  PDF: 947

  Suppl. Files: 614

  HTML: 95

• TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH SINGLE-AGENT ARSENIC TRIOXIDE

  Vikram Mathews, Ezhilarasi Chendamarai, Biju George, Auro Viswabandya, Alok Srivastava

  e2011056

  2011-11-28

  https://doi.org/10.4084/mjhid.2011.056

  3550

  PDF: 895

  HTML: 4426

• Guest Editor: Pellegrino Musto AN UPDATE OF THE APPROPRIATE SEQUENCING FOR SALVAGE THERAPIES IN MULTIPLE MYELOMA

  Gregorio Barila', Francesca Rezzonico, Laura Pavan, Alessandro Corso, Renato Zambello

  e2025043

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.043

  1080

  PDF: 891

  HTML: 124

• CMV Reactivations During and after Letermovir Prophylaxis In Allogeneic Hematopoietic Stem Cell Transplantation: a Single-Center Experience.

  Edoardo Olivari

  e2025079

  2025-10-31

  https://doi.org/10.4084/MJHID.2025.079

  364

  PDF: 181

  Html: 46

• NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?

  Alessandro Corso, Silvia Mangiacavalli

  e2017053

  2017-08-18

  https://doi.org/10.4084/mjhid.2017.053

  3146

  PDF: 1683

  HTML: 1071

• IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW

  Tomasz Sacha

  e2014007

  2013-12-31

  https://doi.org/10.4084/mjhid.2014.007

  4538

  PDF: 2731

  HTML: 2245

• Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA

  Bhavya S Doshi, Valder R Arruda, Valder R Arruda

  e2020069

  2020-09-08

  https://doi.org/10.4084/mjhid.2020.069

  1948

  PDF: 1825

  HTML: 329

• BONE MARROW ABONRMALITIES IN HIV INFECTION

  Sharad Antiram Dhurve

  e2013033

  2013-06-03

  https://doi.org/10.4084/mjhid.2013.033

  1807

  PDF: 1096

  HTML: 1733

• Sickle cell disease and Bartonella spp. infection

  Paulo Eduardo Neves Ferreira Velho, Marna Elise Ericson, David Mair, Kalpna Gupta

  e2012046

  2012-06-30

  https://doi.org/10.4084/mjhid.2012.046

  1108

  PDF: 835

  HTML: 442

• The EVOLVING ROLE OF HAEMATOLOGY NURSING PRACTICE: A CROSS-SECTIONAL SURVEY

  Sarah Liptrott, Mairéad NíChonghaile, Liz O'Connell, Erik Aerts

  e2023033

  2023-04-28

  https://doi.org/10.4084/MJHID.2023.033

  1662

  Suppl. Files: 828

  HTML: 403

  PDF: 705

• TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA

  Michele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, Francesca Palandri, Gianantonio Rosti

  e2014005

  2014-01-02

  https://doi.org/10.4084/mjhid.2014.005

  3229

  PDF: 1430

  HTML: 3975

• OUTCOME OF FRONTLINE TREATMENT WITH “GENERIC” IMATINIB IN ADULT PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN ALGERIAN POPULATION: A MULTICENTER STUDY

  Mohamed Amine BEKADJA

  e2017062

  2017-10-25

  https://doi.org/10.4084/mjhid.2017.062

  2752

  PDF: 693

  HTML: 887

• DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY

  John Norman Greene, Abraham Tareq Yacoub, Dani Thomas, Carol Yuan, Frank Walsh, David Solomon, Skai Schwartz, Arthur Andrews

  e2015002

  2014-12-19

  https://doi.org/10.4084/mjhid.2015.002

  1906

  PDF: 789

  HTML: 2187

  Table 1: 158

  Table 2: 173

  Table 3: 169

  Table 4: 174

  Table 5: 171

  Tble 6: 164

  Cover Letter: 185

  Greene Tab.7: 169

• T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections

  Muhamad R. Abdel Hameed, Sherein G. Elgendy, Mohamed A El-Mokhtar, Douaa Sayed, Samar M. Mansour, Abeer M. Darwish

  e2022022

  2022-02-27

  https://doi.org/10.4084/MJHID.2022.022

  1691

  PDF: 655

  HTML: 314

• Guest Editor: Pellegrino Musto HOW FIRST-LINE THERAPY IS CHANGING IN NON-TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS.

  Daniele Derudas

  e2025025

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.025

  1444

  PDF: 1261

  HTML: 105

• TREATMENT OF ADOLESCENT AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

  Josep-Maria Ribera, Jordi Ribera, Eulàlia Genescà

  e2014052

  2014-07-02

  https://doi.org/10.4084/mjhid.2014.052

  2538

  PDF: 1275

  HTML: 5886

• HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT

  Anna Locasciulli, Barbara Montante, Emanuela Morelli, Virginia Gulino, Anna Proia, Maria Beatrice Pinazzi

  e2009016

  https://doi.org/10.4084/mjhid.2009.016

  931

  PDF: 516

  HTML: 711

• DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA

  Sabina Chiaretti, Gina Zini, Renato Bassan

  e2014073

  2014-10-24

  https://doi.org/10.4084/mjhid.2014.073

  8862

  PDF: 5956

  HTML: 87459

  Fig.1b: 164

  Fig.1c: 165

  Fig.2a: 156

  Fig.2b: 161

  Fig.4: 169

  Fig.2c: 158

  Fig.3: 163

  Tab.1: 212

  Tab.2: 191

  Tab.3: 177

  Tab.4: 198

  Fig1a: 158

• DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES

  Prof. Giuseppe Leone, Emiliano Fabiani, Maria Teresa Voso

  e2022030

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.030

  1296

  HTML: 367

  PDF: 793

• CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA

  Livio Pagano, Morena Caira, Caterina Giovanna Valentini, Luana Fianchi

  e2009030

  https://doi.org/10.4084/mjhid.2009.030

  1229

  PDF: 587

  HTML: 3058

• THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis

  Nicola Semeraro, Prof. Mario Colucci

  e2021045

  2021-06-28

  https://doi.org/10.4084/MJHID.2021.045

  1869

  PDF: 770

  HTML: 204

• RESPIRATORY VIRAL INFECTIONS IN CHILDREN AND ADOLESCENTS WITH HEMATOLOGICAL MALIGNANCIES

  Seung Beom Han, Ju Ae Shin, Seong koo Kim, Jae Wook Lee, Dong-Gun Lee, Nack-Gyun Chung, Bin Cho, Dae Chul Jeong, Jin Han Kang

  e2019006

  2019-01-01

  https://doi.org/10.4084/mjhid.2019.006

  1869

  PDF: 1172

  HTML: 186

• THE JAK2V617F POINT MUTATION INCREASES THE OSTEOCLAST FORMING ABILITY OF MONOCYTES IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS AND MAKES THEIR OSTEOCLASTS MORE SUSCEPTIBLE TO JAK2 INHIBITION

  Emmanouil Spanoudakis, Menelaos Papoutselis, Ioanna Bazntiara, Eleftheria Lamprianidou, Xrisa Kordella, Constantinos Tilkeridis, Constantinos Tsatalas, Ioannis Kotsianidis

  e2018058

  2018-10-27

  https://doi.org/10.4084/mjhid.2018.058

  1282

  PDF: 797

  HTML: 157

• CLINICAL SIGNS AND TREATMENT OF NEW-ONSET BONE MARROW FAILURE ASSOCIATED SARS-COV-2 INFECTION IN CHILDREN : A SINGLE INSTITUTION PROSPECTIVE COHORT STUD

  Mervat A M youssef, Ebtisam Shawky hmed, Dalia Tarik Kamal, khalid Elsayh,, Mai A Abdelfatta, Hyam Hassan Mahran Mahran, Mostafa M Embaby

  e2024034

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.034

  1114

  PDF: 1220

  HTML: 99

• NURSES’ PHYSICAL AND PSYCHOLOGICAL SYMPTOMS DURING THE FIRST COVID-19 LOCKDOWN IN ITALY A nationwide cross-sectional study in stem cell transplantation setting.

  Stefano Botti, Chiara Cannici, Sarah Liptrott, Valentina De Cecco, Elena Rostagno, Gianpaolo Gargiulo, Laura Orlando , Caime Alessandro, Emanuela Samarani, Letizia Galgano, Marco Cioce, Nicola Mordini, Nadia Mandelli, Lucia Tombari, Sara Errichiello, Nicola Celon, Roberto Lupo; Teresa Rea; Nicola Serra

  e2022010

  2022-01-01

  https://doi.org/10.4084/MJHID.2022.010

  1604

  PDF: 796

  HTML: 217

• ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS

  saveria capria, silvia maria trisolini, clara minotti, caterina stefanizzi, luisa cardarelli, Martina Canichella, claudio cartoni, daniela diverio, maria stefania de propris, marco mancini, alessandra micozzi, robin foà, giovanna meloni

  e2012072

  2012-11-06

  https://doi.org/10.4084/mjhid.2012.072

  1644

  PDF: 778

  HTML: 922

  cover letter: 247

• WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE

  Maddalena Mazzucchelli, Anna Maria Frustaci, Marina Deodato, Roberto Cairoli, Alessandra Tedeschi

  e2018004

  2018-01-01

  https://doi.org/10.4084/mjhid.2018.004

  7197

  PDF: 2372

  HTML: 1705

  Table 1.: 183

  Table 2.: 199

  Table 3.: 180

  Table 4.: 179

• TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin

  Cristina Papayannidis, Vincenzo Federico, Luana Fianchi, Patrizia Pregno, Novella Pugliese, Alessandra Romano, Federica Irene Grifoni

  e2022073

  2022-10-29

  https://doi.org/10.4084/MJHID.2022.073

  1160

  PDF: 926

  HTML: 192

• Monoclonal Gammopathy of Undetermined Significance Disguised as Chronic Neutrophilic Leukemia

  Monique A Hartley-Brown, Lubomir Sokol, Gisela L Caceres, Mohammed A Hussein, Alan List, Javier Pinilla-Ibarz

  e2010002

  2010-02-23

  https://doi.org/10.4084/mjhid.2010.002

  966

  PDF: 528

  HTML: 378

• SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.

  Ilhami Berber, Ozlem Cagasar, Ahmet Sarıcı, Nurcan Kirici Berber, Ismet Aydogdu, Asli Yildirim, Harika Gozde Gocukara Bag, Leman Acun Delen, Ozkan Ulutas

  e2021009

  2021-01-01

  https://doi.org/10.4084/mjhid.2021.009

  3131

  PDF: 1022

  HTML: 412

• Madurella mycetomatis infection following allogenic stem cell transplantation for aplastic anemia

  Sanjeev Kumar Sharma, Anjan Mukherjee, Avinash Kumar Singh, Tuika Seth, Suman Kumar, Pravas Mishra, Immaculata Xess, Somesh Gupta, Manoranjan Mahapatra, Haraprasad Pati

  e2012038

  2012-06-13

  https://doi.org/10.4084/mjhid.2012.038

  1388

  PDF: 765

  HTML: 8879

• DEVELOPMENT OF AN IMPROVED EPSTEIN-BARR VIRUS (EBV) NEUTRALIZING ANTIBODY ASSAY TO FACILITATE DEVELOPMENT OF A PROPHYLACTIC GP350-SUBUNIT EBV VACCINE

  Hui Liu, Lorraine Gemmell, Rui Lin, Fengrong Zuo, Henry H. Balfour, Jr., Jennifer C. Woo, Gregory M. Hayes

  e2020016

  2020-02-26

  https://doi.org/10.4084/mjhid.2020.016

  1703

  PDF: 1004

  HTML: 319

• TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.

  Aditi Singh, MD, Ishaq Asghar, MD, Laura Kohler, DO, Hosam Hakim, MD, Daniel Snower, MD, Daniel Lebovic, MD

  e2022018

  2022-02-27

  https://doi.org/10.4084/MJHID.2022.018

  1590

  PDF: 706

  HTML: 457

• RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM

  Ugo Testa, Elvira Pelosi, Germana Castelli, Giuseppe Leone

  e2023062

  2024-06-29

  https://doi.org/10.4084/MJHID.2024.062

  1118

  PDF: 1006

  HTML: 174